Boston Scientific Shares Tumble After Management Lowers Organic Growth Targets
Boston Scientific shares fell sharply after executives disclosed lower organic growth forecasts during a Bernstein investor conference, citing unforeseen headwinds and shifts in business patterns. Management cut full-year and Q2 organic growth expectations and pointed to softening volumes in WATCHMAN and electrophysiology, prompting analyst price-t…